Regulatory B cells in inflammatory diseases and tumor.

As antigen-presenting cells (APC), B cells exert a variety of immune regulatory functions mainly by presenting antigens, triggering immune response, and producing antibodies for immune regulation. Regulatory B cells (Bregs) are special subpopulations of B cells with immune-regulating or immune-suppressing properties and play a role in peripheral tolerance. Bregs suppress immune response through inhibiting the differentiation of dendritic cells (DCs), suppressing the proliferation of helper T1(TH1) cells and helper T17 (TH17) cells, inducing the differentiation of fork head transcription factor p3 positive regulatory T cells (FoxP3+ Tregs). Different subsets of Bregs have distinct phenotypes and markers. Different subsets of Bregs participate in immune modulation by different ways. The absence or loss of Bregs exacerbates the severity of many disease such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and graft-versus-host-disease (GVHD). Bregs are also involved in tumor immunosuppressive effect and inhibit the antitumor immune process. In this article, we review the research advances of Bregs in autoimmune diseases, GVHD and tumor.

• Publication year

  2019

• Venue

  International Immunopharmacology

• Publication date

  2019-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.intimp.2018.12.007PMID 30572252
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting TLRs and the inflammasome in systemic sclerosis

  2018cited by this paper
• Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis

  2017cited by this paper
• A novel MDSC-induced PD-1−PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties

  2017cited by this paper
• Induction and Differentiation of IL-10–Producing Regulatory B Cells from Healthy Blood Donors and Rheumatoid Arthritis Patients

  2017cited by this paper
• Impairment of Granzyme B-Producing Regulatory B Cells Correlates with Exacerbated Rheumatoid Arthritis

  2017cited by this paper
• Decreased CD1d level is associated with CD86 over-expression in B cells from systemic lupus erythematosus

  2017cited by this paper
• The role of regulatory B cells in allergen immunotherapy.

  2017cited by this paper
• The role of regulatory B cells in allergen immunotherapy.

  2017cited by this paper
• Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation

  2017cited by this paper
• Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis

  2016cited by this paper
• CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells.

  2016cited by this paper
• Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients

  2016cited by this paper
• A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus

  2016cited by this paper
• Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses.

  2016cited by this paper
• IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance.

  2016cited by this paper
• PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression.

  2016cited by this paper
• Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases.

  2016cited by this paper
• A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cells.

  2016cited by this paper
• Role of regulatory B cells in immune tolerance to allergens and beyond.

  2016cited by this paper
• Deficient regulatory B cells in human chronic graft-versus-host disease

  2015cited by this paper
• Reduced CD5+CD24hiCD38hi and interleukin‐10+ regulatory B cells in active anti‐neutrophil cytoplasmic autoantibody‐associated vasculitis permit increased circulating autoantibodies

  2015cited by this paper
• B10 Cells: A Functionally Defined Regulatory B Cell Subset

  2015cited by this paper
• CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer

  2015cited by this paper
• Regulatory B10 cell development and function.

  2015cited by this paper
• Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.

  2015cited by this paper
• CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.

  2015cited by this paper
• Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis.

  2014cited by this paper
• cGVHD B(r)egs to differ.

  2014cited by this paper
• IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

  2014cited by this paper
• Autoimmunity: Regulatory B cells—IL-35 and IL-21 regulate the regulators

  2014cited by this paper
• Cellular targets of regulatory B cell-mediated suppression.

  2014cited by this paper
• T Follicular Helper Cells and Regulatory B Cells Dynamics in Systemic Lupus Erythematosus

  2014cited by this paper
• Autoimmunity: Regulatory B cells—IL-35 and IL-21 regulate the regulators

  2014cited by this paper
• Glioma cell-derived placental growth factor induces regulatory B cells.

  2014cited by this paper
• Interleukin-35 Induces Regulatory B Cells that Suppress CNS Autoimmune Disease

  2014cited by this paper
• Characterization and activity of Fas ligand producing CD5⁺ B cells.

  2014cited by this paper
• Interleukin‐10 producing‐B cells and their association with responsiveness to rituximab in myasthenia gravis

  2014cited by this paper
• Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.

  2014cited by this paper
• Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis

  2014cited by this paper
• Donor and host B cell‐derived IL‐10 contributes to suppression of graft‐versus‐host disease

  2014cited by this paper
• Regulatory B10 Cells Are Decreased in Patients With Rheumatoid Arthritis and Are Inversely Correlated With Disease Activity

  2014cited by this paper
• Adaptive immunity in rheumatoid arthritis: anticitrulline and other antibodies in the pathogenesis of rheumatoid arthritis

  2014cited by this paper
• Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10

  2014cited by this paper
• Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab.

  2013cited by this paper
• CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation

  2013cited by this paper
• IL-10-producing regulatory B cells (B10 cells) in autoimmune disease

  2013cited by this paper
• Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.

  2013cited by this paper
• Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator–Activated Receptor α

  2013cited by this paper
• Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells.

  2013cited by this paper
• Immune regulatory function of B cells.

  2012cited by this paper
• Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.

  2012cited by this paper
• Schistosomes Induce Regulatory Features in Human and Mouse CD1dhi B Cells: Inhibition of Allergic Inflammation by IL-10 and Regulatory T Cells

  2012cited by this paper
• Crosstalk between TGF-β signaling and the microRNA machinery.

  2012cited by this paper
• Regulatory B cells play a key role in immune system balance.

  2012cited by this paper
• TGF-β signaling in fibrosis

  2011cited by this paper
• Thymic Stromal Lymphopoietin Is a Key Mediator of Breast Cancer Progression

  2011cited by this paper
• IL-10 is Predominantly Produced by CD19(low)CD5(+) Regulatory B Cell Subpopulation: Characterisation of CD19 (high) and CD19(low) Subpopulations of CD5(+) B cells

  2011cited by this paper
• An update on pathogenic mechanisms of inflammatory myopathies

  2011cited by this paper
• Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus.

  2011cited by this paper
• Pathogenesis, classification and treatment of inflammatory myopathies

  2011cited by this paper
• Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

  2011cited by this paper
• Helminth-induced CD 19 1 CD 23 hi B cells modulate experimental allergic and autoimmune inflammation

  2010cited by this paper
• Effector and regulatory B cells: modulators of CD4+ T cell immunity

  2010cited by this paper
• Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

  2010cited by this paper
• B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer

  2010cited by this paper
• Regulatory B Cells (B10 Cells) and Regulatory T Cells Have Independent Roles in Controlling Experimental Autoimmune Encephalomyelitis Initiation and Late-Phase Immunopathogenesis

  2010cited by this paper
• Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity

  2010cited by this paper
• CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

  2010cited by this paper
• Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis

  2009cited by this paper
• Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.

  2009cited by this paper
• Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity.

  2009cited by this paper
• The Development and Function of Regulatory B Cells Expressing IL-10 (B10 Cells) Requires Antigen Receptor Diversity and TLR Signals1

  2009cited by this paper
• T Cell Infiltrates in the Muscles of Patients with Dermatomyositis and Polymyositis Are Dominated by CD28null T Cells1

  2009cited by this paper
• Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.

  2008cited by this paper
• TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity1

  2008cited by this paper
• A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

  2008cited by this paper
• The 'short' history of regulatory B cells.

  2008cited by this paper
• T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells.

  2008cited by this paper
• Type I interferons protect neonates from acute inflammation through interleukin 10–producing B cells

  2007cited by this paper
• IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells1

  2007cited by this paper
• Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population

  2007cited by this paper
• Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis1

  2007cited by this paper
• B Cell Regulation of CD4+CD25+ T Regulatory Cells and IL-10 Via B7 is Essential for Recovery From Experimental Autoimmune Encephalomyelitis1

  2007cited by this paper
• Differentiation plasticity regulated by TGF-β family proteins in development and disease

  2007cited by this paper
• Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation.

  2006cited by this paper
• Inhibitory effects of B cells on antitumor immunity.

  2006cited by this paper
• B cells play a regulatory role in mice infected with the L3 of Brugia pahangi.

  2005cited by this paper
• TLR11 Activation of Dendritic Cells by a Protozoan Profilin-Like Protein

  2005cited by this paper
• A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

  2005cited by this paper
• Activation of Marginal Zone B Cells from Lupus Mice with Type A(D) CpG-Oligodeoxynucleotides1

  2005cited by this paper
• TLR-9 Activation of Marginal Zone B Cells in Lupus Mice Regulates Immunity Through Increased IL-10 Production

  2005cited by this paper
• Pathogenic roles of B cells in human autoimmunity; insights from the clinic.

  2004cited by this paper
• Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis.

  2003cited by this paper
• B cell developmental requirement for the G alpha i2 gene.

  2003cited by this paper
• The regulation of lupus-associated autoantibodies: immunoglobulin transgenic models.

  2003cited by this paper
• Granzyme B: a natural born killer

  2003cited by this paper
• B Cell Developmental Requirement for the Gαi2 Gene 1

  2003cited by this paper
• Development of autoantibodies before the clinical onset of systemic lupus erythematosus.

  2003cited by this paper
• Fas Ligand-Expressing B-1a Lymphocytes Mediate CD4+-T-Cell Apoptosis during Schistosomal Infection: Induction by Interleukin 4 (IL-4) and IL-10

  2002cited by this paper
• Origins and functions of B-1 cells with notes on the role of CD5.

  2002cited by this paper

• Increase CD24+CD27+ B cells within pleural effusions derived from lung adenocarcinoma presents enhanced potential for clinical utility.

  2025cites this paper
• Immunopathogenesis of Systemic Lupus Erythematosus: Interplay of Innate and Adaptive Immunity, Microbiome Dysbiosis, and Emerging Therapeutic Targets

  2025cites this paper
• Advancements in the use of cancer nanovaccines: Comprehensive insights with focus on lung and colon cancer

  2025cites this paper
• Immunological mechanisms and immunoregulatory strategies in intervertebral disc degeneration

  2025cites this paper
• Unlocking the Therapeutic Potential of Oral Cancer Stem Cell-Derived Exosomes

  2024cites this paper
• Recent progress in cancer vaccines and nanovaccines.

  2024cites this paper
• Genetically predicted hypotaurine levels mediate the relationship between immune cells and intracerebral hemorrhage.

  2024cites this paper
• Autoimmune Diseases and Plasma Cells Dyscrasias: Pathogenetic, Molecular and Prognostic Correlations

  2024cites this paper
• Nanovaccines: An effective therapeutic approach for cancer therapy.

  2023cites this paper
• Crosstalk between peripheral immunity and central nervous system in Alzheimer's disease.

  2023cites this paper
• A quinazoline derivative suppresses B cell hyper-activation and ameliorates the severity of systemic lupus erythematosus in mice

  2023cites this paper
• International society for cell & gene therapy stem cell engineering committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.

  2023cites this paper
• Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential

  2022cites this paper
• Bifidobacterium bifidum H3-R2 and Its Molecular Communication within the Context of Ulcerative Colitis.

  2022cites this paper
• Immune hallmarks of rheumatoid arthritis management: A brief review.

  2022cites this paper
• A Journey through the Inter-Cellular Interactions in the Bone Marrow in Multiple Myeloma: Implications for the Next Generation of Treatments

  2022cites this paper
• B10 Cells Are Associated With Clinical Prognosis During Adult Symptomatic Acute HBV Infection

  2022cites this paper
• Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus

  2022influential citation
• Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma

  2022cites this paper
• The prognostic impact of tumor-infiltrating B lymphocytes in patients with solid malignancies: A systematic review and meta-analysis.

  2022cites this paper
• Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma

  2022cites this paper
• Regulatory B Cell Therapy in Kidney Transplantation

  2021cites this paper
• Endocan, a novel inflammatory marker, is upregulated in human chondrocytes stimulated with IL-1 beta

  2021cites this paper
• Exosomes in Immune Regulation

  2021cites this paper
• Detection and Quantification of Transforming Growth Factor-β1 Produced by Murine B Cells: Pros and Cons of Different Techniques.

  2021cites this paper
• Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma

  2021influential citation
• TGF‐β‐secreting regulatory B cells: unsung players in immune regulation

  2021cites this paper
• Mangiferin Promotes Bregs Level, Activates Nrf2 Antioxidant Signaling, and Inhibits Proinflammatory Cytokine Expression in Murine Splenic Mononuclear Cells In Vitro

  2021cites this paper
• Inflammation and tumor progression: signaling pathways and targeted intervention

  2021cites this paper
• The Dog as a Model to Study the Tumor Microenvironment.

  2021cites this paper
• Tumor immune microenvironment in epidermal growth factor receptor-mutated non-small cell lung cancer before and after epidermal growth factor receptor tyrosine kinase inhibitor treatment: a narrative review

  2021cites this paper
• Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia

  2021cites this paper
• Dual Role of Chondrocytes in Rheumatoid Arthritis: The Chicken and the Egg

  2020cites this paper
• Comprehensive assessment of PD-L1 and PD-L2 dysregulation in gastrointestinal cancers.

  2020cites this paper
• Immune responses against autologous tumor and human papilloma virus in lymph nodes from patients with penile cancer

  2020cites this paper
• Gut Microbiota and Bacterial DNA Suppress Autoimmunity by Stimulating Regulatory B Cells in a Murine Model of Lupus

  2020cites this paper
• Tumor-infiltrating lymphocytes in the immunotherapy era

  2020cites this paper
• Equine Penile Squamous Cell Carcinomas as a Model for Human Disease: A Preliminary Investigation on Tumor Immune Microenvironment

  2020cites this paper
• Astilbin combined with lipopolysaccharide induces IL-10-producing regulatory B cells via the STAT3 signalling pathway.

  2020cites this paper
• Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer

  2020cites this paper
• The Role of Microbiomes in Pregnant Women and Offspring: Research Progress of Recent Years

  2020cites this paper
• Regulatory B Cells.

  2020cites this paper
• B Cells in Immunity and Tolerance

  2020cites this paper
• Activation of immunosuppressive network in the aging process.

  2019cites this paper
• Progranulin Mediates Proinflammatory Responses in Systemic Lupus Erythematosus: Implications for the Pathogenesis of Systemic Lupus Erythematosus

  2019cites this paper